572
Participants
Start Date
May 31, 2012
Primary Completion Date
September 30, 2015
Study Completion Date
September 30, 2016
Freezor Xtra Cryoablation Catheter
Freezor® Xtra Cardiac CryoAblation applied for cryoablation of the conducting tissues of the heart in the treatment of patients with atrioventricular nodal reentrant tachycardia using an endocardial approach.
Montefiore Medical Center, The Bronx
Southside Hospital, Bay Shore
University of Rochester Medical Center, Rochester
Capital Cardiovascular Associates, Camp Hill
Geisinger Medical Center, Danville
Geisinger Wyoming Valley Medical Center, Wilkes-Barre
Virginia Heart, Falls Church
Sanger Heart and Vascular Institute, Charlotte
Piedmont Heart Institute, Atlanta
Orlando Regional Medical Center, Orlando
Baptist Hospital of Miami, Miami
Wellmont Cardiovascular Heart Institute, Kingsport
Cleveland Clinic, Cleveland
Miami Valley Cardiologists, Dayton
University of Michigan Medical Center, Ann Arbor
Iowa Heart Center, Des Moines
Healtheast St. Joseph's Hospital, Saint Paul
Park Nicollet Institute, Saint Louis Park
Advocate Christ Medical Center, Oak Lawn
Baylor Research Institute, Plano
Baylor Heart and Vascular Hospital, Dallas
St. Luke's Episcopal, Houston
Banner Good Samaritan Medical Center, Phoenix
Pacific Heart Institute, Santa Monica
Stanford Hospital and Clinics, Stanford
Sacred Heart Medical Center, Springfield
Royal Alexandra Hospital, Edmonton
Victoria Cardiac Arrhythmia Trials, Inc., Victoria
London Health Sciences Centre, London
Montreal Heart Institute, Montreal
Hopital du Sacre Coeur de Montreal, Montreal
McGill University Health Centre, Montreal
Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke
Prairie CardioVascular Research Network, Regina
Medtronic Cardiac Ablation Solutions
INDUSTRY